logo

For the Inventor, By the Inventor

Basel, Switzerland

Altavant Sciences Gmbh

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 12.5


Trademarks = 3

Forward Citations = 5

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Magdalena Alonso-Galicia (4 out of 4 patents)

silverMedal Steve Wring (3 out of 3 patents)

bronzeMedal Thomas Pack (3 out of 4 patents)

4.  Julie Rurka (3 out of 3 patents)

5.  Melissa Rhodes (3 out of 4 patents)

6.  David J Carpenter (3 out of 25 patents)

7.  Stéphane De Lombaert (2 out of 13 patents)

8.  Daniel R Goldberg (2 out of 53 patents)

9.  Kenneth Albert Brameld (1 out of 27 patents)

10.  Daniel Patterson (1 out of 2 patents)

11.  Shanie Everts (1 out of 1 patent)

12.  Roy C Levitt, Jr (1 out of 3 patents)

13.  Andrew Scribner (1 out of 12 patents)

14.  Eric J Gaukel (1 out of 1 patent)

15.  Stephen A Wring (1 out of 1 patent)


8 patents:

1. 11911382 - Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension (2024-02-27),
2. 11759462 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2023-09-19),
3. 11708365 - Processes for preparing TPH1 inhibitors (2023-07-25),
4. 11607413 - Dosage regime and method for treating pulmonary arterial hypertension (2023-03-21),
5. 11576915 - Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing (2023-02-14),
6. 11413287 - Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension (2022-08-16),
7. 11203597 - Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing (2021-12-21),
8. 11091763 - Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors (2021-08-17),
Company Overview
Altavant Sciences is a clinical-stage pharmaceutical company focused on developing innovative therapies for respiratory diseases. The company's pipeline includes potential treatments for cystic fibrosis and primary ciliary dyskinesia. Altavant Sciences is committed to improving the lives of patients with significant unmet medical needs through groundbreaking research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#46 in Basel

#1,223 in Switzerland

Basel, CH
Basel, Switzerland

Altavant Sciences Gmbh

Forward Citations = 5

17 inventors:

goldMedal Magdalena Alonso-Galicia (4 out of 4 patents)

silverMedal Steve Wring (3 out of 3 patents)

bronzeMedal Thomas Pack (3 out of 4 patents)

4.  Julie Rurka (3 out of 3 patents)

5.  Melissa Rhodes (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Altavant Sciences Gmbh. Retrieved from https://idiyas.com/company/altavant-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…